Therefore, our results suggest that strong Tiam1 overexpression is a new and independent predictor of disease recurrence for patients with prostate cancer and that tumours with strong Tiam1 overexpression require more aggressive treatment. The gene discussed is TIAM1; the disease is prostate carcinoma.